Accounting reportsPreviously
|
Name | APTEKA 5, OAO |
|---|
INN | 6315245781 |
|---|
KPP | 631501001 |
|---|
OGRN | 1026300971894 |
|---|
OKPO | 20963781 |
|---|
FFSM | 00349-E |
|---|
Address | 443001, Samarskaya Oblast', g. Samara, ul. Samarskaya, d. D.203 |
|---|
Phone | +7 (846) 242-39-57 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 68.20 | Core activity | Renting and operating of own or leased land, buildings and dwellings | | 62.01 | Additional activity | Computer programming, consultancy and related activities | | 62.02 | Additional activity | Activities and advisory work in the field of computer technology | | All types of activities | | 68.32 | Additional activity | Management of land, buildings and homes for others | | 70.22 | Additional activity | Advice on business and management | | 73.20 | Additional activity | Market research and public opinion polling |
Registration date | 20.12.2002 |
|---|
Registering department | ADMINISTRATSIYA LENINSKOGO RAYONA GORODA SAMARY |
|---|
|
APTEKA 5, OAO (Samara Oblast; INN 6315245781) was registered on 20 Dec 2002. The company's authorized capital as of July 1, 2012 was 66130 rub. Type of ownership of APTEKA 5, OAO - Open joint-stock companies. Form of ownership of APTEKA 5, OAO - Private property. Principal activities of APTEKA 5, OAO: renting and operating of own or leased land, buildings and dwellings (68.20), computer programming, consultancy and related activities (62.01), activities and advisory work in the field of computer technology (62.02). |
Economic indicators2023
Net profit (RAS) of APTEKA 5, OAO grew over 2023 2.65 times to 4.25 million RUB from 1.61 million RUB over 2022, the company informed. Revenue increased in the accounting period 2.15 times to 5.68 million RUB from 2.64 million RUB over 2022. 2022
Net profit (RAS) of APTEKA 5, OAO dropped in 2022 by 12.47% to 1.61 million RUB from 1.84 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period 2.08 times to 2.64 million RUB from 5.49 million RUB in 2021. 2021
Net profit (RAS) of APTEKA 5, OAO grew over 2021 9.87 times to 1.84 million RUB from 186.00 thousand RUB over 2020, the company informed. Revenue increased in the accounting period by 16.03% to 5.49 million RUB from 4.73 million RUB over 2020. 2020
Net profit (RAS) of APTEKA 5, OAO dropped in 2020 17.96 times to 186.00 thousand RUB from 3.34 million RUB over the same period in 2019, the company informed. Revenue increased in the accounting period by 6.46% to 4.73 million RUB from 4.44 million RUB over 2019. 2019
Net profit (RAS) of APTEKA 5, OAO grew over 2019 by 29.60% to 3.34 million RUB from 2.58 million RUB over 2018, the company informed. Revenue increased in the accounting period by 6.58% to 4.44 million RUB from 4.17 million RUB over 2018. 2018
Net profit (RAS) of APTEKA 5, OAO grew over 2018 2.61 times to 2.58 million RUB from 988.00 thousand RUB over 2017, the company informed. Revenue decreased in the accounting period by 43.16% to 4.17 million RUB from 7.33 million RUB in 2017; cost of goods sold decreased 4.18 times to 1.48 million RUB from 6.18 million RUB; sales profit went up 2.33 times to 2.69 million RUB from 1.16 million RUB. 2017
Net profit (RAS) of APTEKA 5, OAO dropped in 2017 by 2.37% to 988.00 thousand RUB from 1.01 million RUB over the same period in 2016, the company informed. Revenue increased in the accounting period by 17.16% to 7.33 million RUB from 6.26 million RUB over 2016; cost of goods sold grew by 21.56% to 6.18 million RUB from 5.08 million RUB; sales profit fell by 1.78% to 1.16 million RUB from 1.18 million RUB. 2016
Net profit (RAS) of APTEKA 5, OAO dropped in 2016 6.87 times to 1.01 million RUB from 6.95 million RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 19.54% to 6.26 million RUB from 7.78 million RUB in 2015; cost of goods sold grew 8.65 times to 5.08 million RUB from 587.00 thousand RUB; sales profit fell 6.11 times to 1.18 million RUB from 7.19 million RUB. 2014
Net profit (RAS) of Apteka 5, OAO grew over 2014 1.51 times to 6.09 million RUB from 4.03 million RUB over 2013, the company informed. Revenue increased in the accounting period by 41.27% to 6.99 million RUB from 4.95 million RUB over 2013; cost of goods sold decreased by 2.08% to 706.00 thousand RUB from 721.00 thousand RUB; sales profit went up by 48.66% to 6.28 million RUB from 4.23 million RUB. 2013
Net profit (RAS) of Apteka 5, OAO dropped in 2013 by 5.94% to 4.03 million RUB from 4.28 million RUB over the same period in 2012, the company informed. Revenue decreased in the accounting period by 12.40% to 4.95 million RUB from 5.65 million RUB in 2012; cost of goods sold decreased by 21.46% to 721.00 thousand RUB from 918.00 thousand RUB; sales profit fell by 10.64% to 4.23 million RUB from 4.73 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|